MRK250110C140000
- 0.00
- 0.000.00%
Merck & Co Newsroom
Wednesday Market Falls, Quantum Computing Pulls Back Hard on Treasury Yield Crunch | Live Stock
Merck Rival Summit Draws New Buy From Truist on Deal Prospects
Merck, Johnson & Johnson Share Losses Lead Dow's 180-Point Fall
Global Equities Roundup: Market Talk
Merck's Near-Term Growth Path Uncertain -- Market Talk
Merck Gets Expanded Approval From China for Its HPV Vaccine in Males
Salesforce To Rally More Than 23%? Here Are 10 Top Analyst Forecasts For Wednesday
Truist Financial Maintains Merck & Co(MRK.US) With Hold Rating, Maintains Target Price $110
UBS Maintains Merck & Co(MRK.US) With Buy Rating, Cuts Target Price to $120
Express News | Merck & Co Inc : Truist Securities Cuts Target Price to $110 From $130
This Adobe Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday
Merck (NYSE:MRK) Has A Pretty Healthy Balance Sheet
Merck Cut to Hold From Buy by Truist Securities
U.S. Stock Outlook | All three Equity Index futures are down, new news on Trump's tariffs, the U.S. stock market will be closed on Thursday.
On January 8th (Wednesday) during Pre-Market Trading, the three major Equity Index futures in the U.S. all fell.
Merck & Co Analyst Ratings
Merck's male HPV vaccine has been approved domestically for the first time. Industry insiders believe this will promote the future approval of domestic products under development.
① Gardasil has become the first and currently the only approved HPV vaccine for men in China. ② Industry experts believe that the approval of the new indication is a new exploration in terms of pharmacological principles and other aspects. ③ Currently, companies such as Kang Li Wei Shi and Beijing Wantai Biological Pharmacy Enterprise have made arrangements in this field.
Open up new markets! Merck (MRK.US) Gardasil becomes the first approved male HPV vaccine in China.
After the vaccination craze among women gradually subsides, it opens up an undeveloped new market for this pharmaceutical giant in the USA.
Express News | Merck China: Chinese National Medical Products Administration Has Approved Hpv Vaccine for Men
Truist Financial Downgrades Merck & Co(MRK.US) to Hold Rating, Cuts Target Price to $110
Tuesday Market Pulls Back After Nvidia All Time High | Wall Street Today